A Phase I/II IST evaluating bavituximab in combination with sorafenib in up to 48 patients with advanced hepatocellular carcinoma (liver cancer) has completed enrollment of the Phase II portion and data from this trial are expected to be presented at an upcoming conference.
It does say enrolled, even though it STILL says "Recruiting" on clinicaltrials.gov: (I don't know WHY it was updated on 9/4/2014 since they left "Recruiting" intact) (http://clinicaltrials.gov/ct2/archive/NCT01264705)
UT Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Adam C Yopp, MD adam.yopp@utsouthwestern.edu Principal Investigator: Adam C Yopp, MD
As of September, it says "Enrollment complete" for liver cancer in the pipeline graph, even though they revised the sliders a bit: September: April:
AI
